VFH vs XBI
Vanguard Financials ETF vs SPDR S&P Biotech ETF
- • VFH has the lower expense ratio at 0.09% vs 0.35% for XBI.
- • VFH pays a higher dividend yield (1.77%).
Side-by-side metrics
| Metric | VFH | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.09% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.77% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $13.81B | $10.73B |
YTD return | 1.73% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.83 | 1.10 |
P/E ratio | 16.77 | — |
Last price | $136.14 | $164.01 |
Inception | — | — |
Issuer | Vanguard | State Street |
VFH top holdings
| JPM | JPMorgan Chase & Co | 8.83% |
| BRK-B | Berkshire Hathaway Inc Class B | 7.77% |
| MA | Mastercard Inc Class A | 4.76% |
| BAC | Bank of America Corp | 4.13% |
| V | Visa Inc Class A | 4.10% |
| GS | The Goldman Sachs Group Inc | 3.38% |
| MS | Morgan Stanley | 2.90% |
| WFC | Wells Fargo & Co | 2.80% |
| C | Citigroup Inc | 2.39% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About VFH
VFH (Vanguard Financials ETF) is US financial services sector stocks. Managed by Vanguard, the fund carries $13.8B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.77%. Its largest holding is JPMorgan Chase & Co (JPM), which represents 8.8% of the portfolio. Real Estate is the fund's largest sector exposure at 0.8%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.